Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.35 |
| ▸ | FLT3 | P36888 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.34 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.34 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1630455 | 0.90 | HSP90AA1 (0.50) | HSP90AA1CYP19A1NR3C2NR1H3KCNN4 | |
| SCHEMBL1630379 | 0.86 | HSP90AA1 (0.48) | HSP90AA1CYP19A1NR3C2FLT3NR1H3 | |
| SCHEMBL1629523 | 0.85 | PTGER1 (0.48) | HSP90AA1NR3C2PTGER1 | |
| SCHEMBL12722876 | 0.83 | HSP90AA1 (0.46) | HSP90AA1NR3C2KCNN4PTGER1P2RX7 | |
| SCHEMBL1629891 | 0.81 | HSP90AA1 (0.43) | HSP90AA1NR3C2PTGER1 | |
| SCHEMBL1629937 | 0.78 | HSP90AA1 (0.45) | HSP90AA1CYP19A1NR3C2KCNN4 | |
| SCHEMBL12722780 | 0.76 | PDE10A (0.44) | HSP90AA1CYP19A1PTGER1 | |
| SCHEMBL1630429 | 0.76 | PTGER1 (0.46) | HSP90AA1NR3C2KCNN4PTGER1 | |
| SCHEMBL1629564 | 0.75 | HSP90AA1 (0.44) | HSP90AA1NR3C2FLT3KCNN4P2RX7 | |
| SCHEMBL1629896 | 0.75 | KCNN4 (0.44) | HSP90AA1NR3C2FLT3KCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1776346-B1 | 1,5-Diphenylpyrazoles | MERCK PATENT GMBH (DE) | 2013-06-26 | — | — | EP | disclosed |
| US-7932401-B2 | Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant | MERCK PATENT GMBH (DE) | 2011-04-26 | — | — | US | disclosed |
| US-20080085904-A1 | 1,5-Diphenylpyrazoles | MERCK PATENT GMBH (DE) | 2008-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080085904-A1 | 1,5-Diphenylpyrazoles | HSP90AB1, HSP90AA1, HSP90AB2P | HSP90AA1 2/4885CYP19A1 1990/4885NR3C2 558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.